Durvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable, previously untreated metastatic colorectal cancer (MCRC): Results of the first intermediate analysis of the phase Ib/II MEDETREME trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreDurvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable, previously untreated metastatic colorectal cancer (MCRC): Results of the first intermediate analysis of the phase Ib/II MEDETREME trial.
Type de publicationJournal Article
Year of Publication2020
AuteursGhiringhelli F, Chibaudel B, Taieb J, Bennouna J, Martin-Babau J, Fonck M, Borg C, Cohen R, Thibaudin M, Limagne E, Fumet J-D
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume38
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X